Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00858481 · ClinicalTrials.gov registry record · Phase 2
A Pilot Dose Ranging Study of Spinosad Creme Rinse
A Phase 2 study of Head Lice and Pediculosis Capitis, sponsored by ParaPRO.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00858481: Completed Phase 2 study of Head Lice and Pediculosis Capitis, sponsored by ParaPRO.
NCT00858481 is a Phase 2 study of Head Lice and Pediculosis Capitis that has completed, run by ParaPRO. The registered enrollment target is 36 participants, below the 110-participant average among 5 other Head Lice trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00858481, a Phase 2 study of Head Lice and Pediculosis Capitis, has completed, sponsored by ParaPRO.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.
Conditions Studied
Interventions
- DRUG Spinosad Creme Rinse - Vehicle Control
- DRUG Spinosad Creme Rinse
Study Locations (1)
Florida
- Hill Top Research - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-09 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
What the finished NCT00858481 record still lists
NCT00858481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 110-participant average among 5 other Head Lice trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which Spinosad Creme Rinse - Vehicle Control is the first listed.
NCT00858481 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00858481 about?
NCT00858481 is a clinical study titled "A Pilot Dose Ranging Study of Spinosad Creme Rinse". A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.
What is the current status of trial NCT00858481?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2005-09. Estimated completion is 2005-11.
What conditions does trial NCT00858481 study?
This clinical trial studies the following conditions: Head Lice, Pediculosis Capitis.
What interventions are being tested in trial NCT00858481?
The interventions under investigation include: Spinosad Creme Rinse - Vehicle Control (DRUG), Spinosad Creme Rinse (DRUG).
Who is sponsoring clinical trial NCT00858481?
This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00858481 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Lice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pediatric Head Lice Study Product Comparison
COMPLETED · Phase 2
-
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
COMPLETED · Phase 2
-
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
RECRUITING · NA
-
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
COMPLETED · NA
-
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia